Please assess the completion status of the following clinical trial:

Trial Title: Inhaled Corticosteroids Versus Observation for Patients With Decreased Lung Function Status

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients \>/=18 years of age.~2. Patients must be engrafted and at least 80 days post allogeneic hematopoietic stem cell transplantation.~3. New onset airflow obstruction defined as decline of forced expiratory volume in 1 second (FEV1) percent predicted \>/= 15%.~4. Total Lung Capacity (TLC) \> 85% to rule out restrictive lung disease.~5. Patient must be willing to comply with all study procedures and capable of signing informed consent.~Exclusion Criteria:~1. Patients with active pulmonary infection.~2. Patients with known hypersensitivity to corticosteroids

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluticasone Propionate (Type: EXPERIMENTAL): 440 micrograms twice daily by oral inhalation.
- Observational Group (Type: NO_INTERVENTION): Comparator group, no intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).